Deutsch English Français

Contact

EP0913161

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...

Extract from the Register of European Patents

EP About this file: EP0913161

EP0913161 - Use of a 13C-labelled amino acid as a diagnostic agent for diabetes [Right-click to bookmark this link]
Former [1999/18]	Diagnostic agent for diabetes
	[2002/38]
Status	No opposition filed within time limit Status updated on 30.01.2004 Database last updated on 05.07.2024
Most recent event Tooltip	30.01.2004	No opposition filed within time limit	published on 17.03.2004 [2004/12]
Applicant(s)	For all designated states TOKYO GAS CO., LTD. 5-20, Kaigan 1-chome, Minato-ku Tokyo 105-8527 / JP
	[N/P]
Former [1999/18]	For all designated states Tokyo Gas Co., Ltd. 5-20, Kaigan 1-chome, Minato-ku Tokyo 105-8527 / JP
Inventor(s)	01 / Kohno, Tadashi 3-5-603, Fuda, Tama-ku Kawasaki-shi, Kanagawa 230-0045 / JP
	02 / Hosoi, Isaburo 340-4, Yanagishimacho Souka-shi, Saitama 340-0033 / JP
	03 / Ohshima, Junko 2-19-4-307, Edahigashi, Tsuduki-ku Yokohama-shi, Kanagawa 224-0006 / JP
	04 / Ito, Asuka 274-8, Toriyama-cho, Kouhoku-ku Yokohama-shi, Kanagawa 222-0035 / JP
	05 / Shibata, Kunihiko 104-1-405, Takidaicho Funabashi-shi, Chiba 274-0045 / JP
	[1999/18]
Representative(s)	Harrison, David Christopher, et al Mewburn Ellis LLP City Tower 40 Basinghall Street London EC2V 5DE / GB
	[N/P]
Former [1999/18]	Harrison, David Christopher, et al MEWBURN ELLIS York House 23 Kingsway London WC2B 6HP / GB
Application number, filing date	98308523.4	19.10.1998
	[1999/18]
Priority number, date	JP19970288526	21.10.1997 Original published format: JP 28852697
	JP19970288629	21.10.1997 Original published format: JP 28862997
	JP19970313077	14.11.1997 Original published format: JP 31307797
	JP19970313763	14.11.1997 Original published format: JP 31376397
	JP19970320805	21.11.1997 Original published format: JP 32080597
	JP19970341154	11.12.1997 Original published format: JP 34115497
	JP19980006410	16.01.1998 Original published format: JP 641098
	JP19980024613	05.02.1998 Original published format: JP 2461398
	JP19980024614	05.02.1998 Original published format: JP 2461498
	[1999/18]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	EP0913161
	Date:	06.05.1999
	Language:	EN
	[1999/18]
	Type:	A3 Search report
	No.:	EP0913161
	Date:	30.08.2000
	[2000/35]
	Type:	B1 Patent specification
	No.:	EP0913161
	Date:	26.03.2003
	Language:	EN
	[2003/13]
Search report(s)	(Supplementary) European search report - dispatched on:	EP	19.07.2000
Classification	IPC:	A61K51/04, A61P43/00	[2002/38]
	CPC:	A61K51/1206 (EP,US); A61K49/1815 (EP,US); A61P3/00 (EP); A61P43/00 (EP)
	Former IPC [1999/18]	A61K51/04
Designated contracting states	DE, ES, FR, GB, IT, SE [2001/20]
Former [1999/18]	AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE
Title	German:	Verwendung einer 13C-markierten Aminosäure zur Diagnose von Diabetes	[2002/38]
	English:	Use of a 13C-labelled amino acid as a diagnostic agent for diabetes	[2002/38]
	French:	Utilisation d'un acid aminé marqué au 13C comme agent diagnostique du diabète	[2002/39]
	Former [1999/18]	Diagnostisches Mittel für Diabetes
	Former [1999/18]	Diagnostic agent for diabetes
	Former [1999/18]	Agent diagnostique pour diabete
Examination procedure	29.09.2000	Examination requested [2000/48]
	23.08.2001	Despatch of a communication from the examining division (Time limit: M04)
	20.12.2001	Reply to a communication from the examining division
	26.02.2002	Despatch of a communication from the examining division (Time limit: M04)
	10.05.2002	Reply to a communication from the examining division
	30.08.2002	Communication of intention to grant the patent
	09.01.2003	Fee for grant paid
	09.01.2003	Fee for publishing/printing paid
Divisional application(s)	EP03000243.0 / EP1304124
Opposition(s)	30.12.2003	No opposition filed within time limit [2004/12]
Fees paid	Renewal fee
	25.10.2000	Renewal fee patent year 03
	23.10.2001	Renewal fee patent year 04
	22.10.2002	Renewal fee patent year 05
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[PX]EP0826377 (TOKYO GAS CO LTD [JP]) [PX] 1,16,17 * abstract *;
		[E]EP0908187 (TOKYO GAS CO LTD [JP]) [E] 1,16,17 * example 4; claims 3,7 *;
		[E]WO9956790 (ISOTECHNIKA INC [CA], et al) [E] 1,16,17 * abstract *;
		[Y]EP0503832 (TOKYO GAS CO LTD [JP]) [Y] 1,16,17 * page 5, line 44 - page 6, line 15 * * abstract *;
		[X]WO9205270 (UNIV TEXAS [US]) [X] 1,16,17 * abstract * * page 4 * * page 12, line 15 - page 14, line 15; figure 1 *;
		[X]WO9201937 (UNIV TEXAS [US]) [X] 1,16,17 * abstract *;
		[X] - D RATING ET AL, "Breath tests: concepts, applications and limitations", EUROPEAN JOURNAL OF PEDIATRICS,XX,SPRINGER VERLAG, vol. 156, no. SUPPL. 01, ISSN 0340-6199, page 18-23, XP002089102 [X] 1,16,17 * abstract *
		[X] - HELGE ET AL, "Carbon-13 dioxide breath tests in normal and diabetic children following ingestion of 13C-glucose", EMBL NUCLEOTIDE SEQU, XP002120262 [X] 1,16,17 * abstract *
		[X] - TANIS ET AL, "Human liver glycogen metabolism assessed with a 13C-enriched diet and a 13CO2 breath test", ABSTRACT BULLETIN OF, XP002120263 [X] 1,16,17 * abstract *
		[X] - HIRAI ET AL, "The breath test using pure (1-13C) glucose: A new simple method for evaluating the glucose oxidation capacity", DIABETOLOGIA, (199706), vol. 40, page a278, XP000865704 [X] 1,16,17 * abstract *
		[Y] - G T BERRY ET AL, "In Vivo Oxidation of [13C]Galactose in Patients with Galactose -1-Phosphate Uridyltransferase Deficiency", BIOCHEMICAL AND MOLECULAR MEDICINE,US,ORLANDO, FL, vol. 56, ISSN 1077-3150, page 158-165, XP002089101 [Y] 1,16,17 * page 158 * * abstract * DOI: http://dx.doi.org/10.1006/bmme.1995.1071

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.1.24; 34p